SCHEMBL9903992

SCHEMBL9903992

CCn1c(=O)[nH]c2nc(-c3cn(Cc4cccc(C(F)(F)F)c4)nn3)[nH]c2c1=O

nearest known ligand 0.72

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 20/20 0.72
ADORA3 P0DMS8 14/20 0.63
ADORA2A P29274 13/20 0.63
ADORA1 P30542 12/20 0.58
PLK4 O00444 1/20 0.52
CDK2 P24941 1/20 0.52
IRAK1 P51617 1/20 0.52
RPS6KA3 P51812 1/20 0.52
PLK3 Q9H4B4 1/20 0.52
CSNK1G3 Q9Y6M4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9904084 0.93 ADORA2B (0.73) ADORA2BADORA3ADORA2AADORA1PLK4
SCHEMBL9904195 0.87 ADORA2B (0.73) ADORA2BADORA3ADORA2AADORA1PLK4
SCHEMBL1945825 0.84 ADORA2B (1.00) ADORA2BADORA3ADORA2AADORA1PLK4
SCHEMBL9904089 0.79 ADORA2B (0.55) ADORA2BADORA3ADORA2AADORA1PLK4
SCHEMBL9903991 0.79 ADORA2A (0.72) ADORA2BADORA3ADORA2AADORA1PLK4
SCHEMBL9904021 0.77 ADORA2B (0.60) ADORA2BADORA3ADORA2AADORA1PLK4
SCHEMBL242942 0.77 ADORA2B (1.00) ADORA2BADORA3ADORA2AADORA1PLK4
SCHEMBL9904033 0.77 ADORA2B (0.75) ADORA2BADORA3ADORA2AADORA1PLK4
SCHEMBL1944981 0.76 ADORA2B (1.00) ADORA2BADORA3ADORA2AADORA1PLK4
SCHEMBL1947163 0.75 ADORA2B (1.00) ADORA2BADORA3ADORA2AADORA1PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed
WO-2012076974-A1 8-TRIAZOLYLXANTHINE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS LIFE & BRAIN GMBH (DE) 2012-06-14 WO disclosed
WO-2012076974-A1 8-TRIAZOLYLXANTHINE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS LIFE & BRAIN GMBH (DE) 2012-06-14 WO disclosed